CN112274462B - Composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects and preparation and application thereof - Google Patents

Composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects and preparation and application thereof Download PDF

Info

Publication number
CN112274462B
CN112274462B CN202010978341.1A CN202010978341A CN112274462B CN 112274462 B CN112274462 B CN 112274462B CN 202010978341 A CN202010978341 A CN 202010978341A CN 112274462 B CN112274462 B CN 112274462B
Authority
CN
China
Prior art keywords
bacteriostatic agent
extract
composite
mixture
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010978341.1A
Other languages
Chinese (zh)
Other versions
CN112274462A (en
Inventor
***
张阳
魏春花
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhiranya Shanghai Cosmetics Co ltd
Zhejiang Semir Garment Co ltd
Original Assignee
Zhiranya Shanghai Cosmetics Co ltd
Zhejiang Semir Garment Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhiranya Shanghai Cosmetics Co ltd, Zhejiang Semir Garment Co ltd filed Critical Zhiranya Shanghai Cosmetics Co ltd
Priority to CN202010978341.1A priority Critical patent/CN112274462B/en
Publication of CN112274462A publication Critical patent/CN112274462A/en
Application granted granted Critical
Publication of CN112274462B publication Critical patent/CN112274462B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • A61K2800/524Preservatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a composite bacteriostatic agent with bacteriostatic and epidermis moisturizing effects, and a preparation method and an application thereof.

Description

Composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects and preparation and application thereof
Technical Field
The invention relates to the field of cosmetics, in particular to a composite bacteriostatic agent with bacteriostatic and epidermis moisturizing effects and preparation and application thereof.
Background
Along with the development of economy and the improvement of living standard of people, the frequency of using cosmetics is higher and higher, and the requirements of people on the safety and the quality of the cosmetics are higher and higher. Good bacteriostats are not only required to prevent and inhibit the growth of microorganisms such as bacteria and fungi, but also must be safe, mild, non-toxic and non-irritating to the human body, non-reactive with other chemical components of the formulation, and provide the desired bacteriostatic function during storage and use of the cosmetic.
Traditionally, the bacteriostatic agent used in cosmetics adopts one or more of 51 preservatives allowed by cosmetic rules, and is compounded to solve the problem of microbial growth of the cosmetics. Because traditional antiseptic itself is the restricted use material, solve cosmetics microorganism growth with a certain antiseptic alone, be difficult to guarantee the effect, and need improve the quantity, improve the quantity and can bring the product security problem. Therefore, there is a tendency that the use of conventional preservatives in cosmetics is less and less.
In view of the above, those skilled in the art have endeavored to develop new safe, mild, non-irritating bacteriostatic products.
Disclosure of Invention
The invention aims to provide a composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects, and preparation and application thereof.
In a first aspect of the invention, a composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects is provided, and comprises nano silver, a plant extract and a plant polysaccharide extract.
Preferably, the composite bacteriostatic agent comprises the following components in parts by weight:
0.0001 to 1 portion of nano silver
0.01-20 parts of plant extract; and
0.01-20 parts of plant polysaccharide extract.
Preferably, the composite bacteriostatic agent comprises the following components in parts by weight:
0.01 to 0.2 portion of nano silver
0.1-20 parts of plant extract; and
1-20 parts of plant polysaccharide extract.
Preferably, the plant extract is selected from one or more of the following group: neem extract, artemisia argyi plant extract, and rosemary plant extract.
Preferably, the plant polysaccharide extract is selected from one or more of the group consisting of: polysaccharide extract of Orchidaceae plant, and Tremella polysaccharide extract.
Preferably, the orchid family plant comprises one or more of cymbidium, cymbidium and cymbidium.
Preferably, the composite bacteriostatic agent further comprises saponin and/or glycyrrhetinic acid.
Preferably, the composite bacteriostatic agent comprises the following components in parts by weight:
Figure 1
in a second aspect of the invention, there is provided the use of the composite bacteriostatic agent of the first aspect of the invention in the preparation of a cosmetic.
Preferably, the cosmetics comprise skin-care lotion, skin-care emulsion, hand sanitizer and shower gel.
In a third aspect of the invention, a cosmetic is provided, which comprises the composite bacteriostatic agent of the first aspect of the invention.
Preferably, the cosmetics comprise skin-care lotion, skin-care emulsion, hand sanitizer and shower gel.
The fourth aspect of the invention provides a preparation method of a composite bacteriostatic agent, which comprises the following steps:
(1) Mixing the raw materials of the composite bacteriostatic agent, and stirring the mixture at 40-80 ℃ to form a uniform mixture;
(2) Adjusting the pH value of the mixture to 5.0-8.0;
(3) Filtering the mixture, and cooling to room temperature to obtain the composite bacteriostatic agent;
wherein, the raw materials of the composite bacteriostatic agent comprise nano silver, plant extracts and plant polysaccharide extracts.
Preferably, the raw materials of the composite bacteriostatic agent comprise the following components in parts by weight:
0.0001 to 1 portion of nano silver
0.01-20 parts of plant extract; and
0.01-20 parts of plant polysaccharide extract.
Preferably, the raw materials of the composite bacteriostatic agent comprise the following components in parts by weight:
0.01 to 0.2 portion of nano-silver
0.1-20 parts of plant extract; and
1-20 parts of plant polysaccharide extract.
Preferably, the plant extract is neem tree extract.
Preferably, the plant polysaccharide extract is an orchid polysaccharide extract.
Preferably, the orchidaceae plant is gymnadenia conopsea.
Preferably, the raw materials of the composite bacteriostatic agent also comprise saponin and/or glycyrrhetinic acid.
Preferably, the raw materials of the composite bacteriostatic agent comprise the following components in parts by weight:
Figure BDA0002686658180000031
it is to be understood that within the scope of the present invention, the above-described features of the present invention and those specifically described below (e.g., in the examples) may be combined with each other to form new or preferred embodiments. Not to be reiterated herein, but to the extent of space.
Drawings
FIG. 1 is a diagram of a finished product prepared in example 1 of the present invention;
FIG. 2 is a schematic view of the antibacterial test method in example 2 of the present invention.
Detailed Description
The inventor obtains a composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects through extensive and intensive research, wherein the composite bacteriostatic agent comprises nano silver, a plant extract and a plant polysaccharide extract, can effectively inhibit the growth of microorganisms in cosmetics, has an excellent skin epidermal moisturizing effect, and has the characteristics of safety, mildness and no irritation.
Before the present invention is described, it is to be understood that this invention is not limited to the particular methodology and experimental conditions described, as such methods and conditions may vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present invention will be limited only by the appended claims.
Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. As used herein, the term "about" when used in reference to a specifically recited value means that the value may vary by no more than 1% from the recited value. For example, as used herein, the expression "about 100" includes 99 and 101 and all values in between (e.g., 99.1, 99.2, 99.3, 99.4, etc.).
Although any methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials are now exemplified.
In a preferred embodiment of the invention, the invention provides a composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects, which consists of nano-silver, a plant extract and a plant polysaccharide extract.
In a preferred embodiment, the composite bacteriostatic agent comprises the following components in parts by weight:
about 0.001 to 1 portion of nano silver
About 0.01-20 parts of plant extract; and
about 0.01-20 parts of plant polysaccharide extract.
In a preferred embodiment, the composite bacteriostatic agent comprises the following components in parts by weight:
Figure BDA0002686658180000041
as described in the present invention, the term "Nano Silver" (Nano Silver) is a metallic Silver simple substance with a Nano-scale particle size, and is a novel inorganic antibacterial material having stable physical, chemical and biological properties and an antibacterial effect which is not comparable to that of the conventional inorganic antibacterial material. The nano silver has high safety and lasting effect, and is a long-acting antibacterial agent. The inventor finds that if the skin care product containing nano silver is applied on the skin, the bacteriostatic effect of the nano silver is obviously reduced along with the evaporation of water. After the plant polysaccharide extract with the strong water locking function is added, the bacteriostatic effect of the nano-silver can be remarkably improved.
As used herein, the term "plant extract" refers to a substance extracted or processed from a plant (whole or a part of a plant) using a suitable solvent or method, and can be used in the pharmaceutical industry, food industry, health industry, cosmetic industry, and other industries.
The plant extract of the present invention is preferably neem tree extract. Melia azedarach L.is an arbor of the Meliaceae family, the genus Melia, deciduous trees, up to 10 meters in height; the bark is gray brown, the branches are wide and spread, the leaves are 2-3 times odd feathery compound leaves, the small She Duisheng, the leaves are oval, elliptical or scaly, and the apical side is slightly larger.
As used herein, the term "plant polysaccharide extract" is a substance extracted from a plant and having a polysaccharide as a main component. The polysaccharide is a general name of a polymer formed by connecting monosaccharides through glycosidic bonds, and a large number of hydrophilic hydroxyl groups enable many polysaccharides to show some excellent physicochemical properties, such as strong water absorption and good film forming property. The pure natural plant polysaccharide not only has excellent moisturizing performance, but also meets the requirements of people on safety and environmental protection. The plant polysaccharide extract forms a water-containing film on the surface of the skin to lock water, so that the nano-silver can be ensured to be in a water-containing environment for a long time, and the bacteriostatic effect of the nano-silver can be exerted to the greatest extent.
The plant polysaccharide extract in the present invention is preferably an orchid polysaccharide extract, and most preferably an extract of Gymnadenia conopsea (l.) r.br.).
As used herein, the term "saponin" is a glycoside whose aglycone is a triterpene or spirostane compound, and is mainly distributed in plants such as terrestrial plateau and is present in a small amount in marine organisms such as starfish and sea cucumber. The main effective components of many Chinese herbal medicines such as ginseng, polygala root, platycodon root, liquorice, rhizoma anemarrhenae, radix bupleuri and the like contain saponin. Some saponins also have antibacterial activity or antipyretic, sedative, and anticancer activities. The saponin is preferably the gleditschia horrida saponin, and is an extract derived from the fruit of the gleditschia horrida.
As used herein, the term "glycyrrhetic acid" is formed by hydrolysis of glycyrrhetic acid to remove sugar acid chains, has a sweetness of 250 times that of sucrose, is an active ingredient of licorice, and is extracted from licorice root.
The main advantages of the invention are:
(1) The composite bacteriostatic agent adopts the following raw materials except 51 preservatives allowed by 3 cosmetic laws: the nano-silver, the plant extract and the plant polysaccharide extract are safer, milder and have no stimulation.
(2) The composite bacteriostatic agent disclosed by the invention is prepared by compounding the nano-silver, the chinaberry tree extract and the plant polysaccharide extract, so that the problem that the nano-silver is easy to aggregate and precipitate is solved, and the nano-silver can be more conveniently used in cosmetics.
(3) Because the nano silver can release silver ions with strong charges, and the plant polysaccharide extract contains a large amount of polysaccharide and protein substances, the charge balance is easily damaged by the silver ions to cause flocculent precipitate.
(4) According to the composite bacteriostatic agent, the nano-silver, the chinaberry extract and the plant polysaccharide extract are compounded, so that the bacteriostatic ability is remarkably improved, and a synergistic technical effect is achieved among the components.
(5) The composite bacteriostatic agent disclosed by the invention is prepared by compounding nano-silver, a chinaberry tree extract and a plant polysaccharide extract, so that the long-time moisturizing capability is obviously improved.
The present invention will be described in further detail with reference to the following examples. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. Experimental procedures for conditions not specified in detail in the following examples are generally carried out under conventional conditions such as those described in molecular cloning, A laboratory Manual (Huang Peitang, eds., beijing: scientific Press, 2002, USA, sambrook, et al, USA, or under conditions recommended by the manufacturer. Unless otherwise indicated, percentages and parts are by weight. The test materials and reagents used in the following examples are commercially available without specific reference.
Specifically, the nano-silver of the present invention is available from heter international (shanghai) limited. Gymnadenia conopsea extract (water extract of gymnadenia conopsea root tuber 50). Neem tree EXTRACT (water EXTRACT of neem domimeticum EXTRACT, neem seed 30. Saponins (water extract of Gleditsia sinensis fruit 50. Glycyrrhetinic acid was obtained from Tanshan pharmaceutical Co.
EXAMPLE 1 Complex bacteriostatic Components proportioning Screen
In the research, the nano silver is directly added into the cosmetics, and is easy to aggregate and precipitate. In addition, the nano silver can release silver ions with strong charges, and the plant polysaccharide extract contains a large amount of polysaccharide and protein substances, so that the silver ions can easily destroy the charge balance to cause flocculent precipitation. Therefore, the present invention has conducted a number of screening tests in order to obtain a stable formulation system.
Some of the test data are listed below.
The preparation method of each composition comprises the following steps:
1) Putting the raw materials into an emulsifying pot, mixing the raw materials together, and stirring the mixture into a uniform mixture at the temperature of between 40 and 80 ℃;
2) Adjusting the pH of the mixture to 5.0-8.0
3) Filtering the mixture in the emulsifying pot, cooling the filtered mixture to room temperature, standing for 7d, and observing.
The contents of the components in the following table are the mass percentage contents added in the traditional cosmetic water. The conventional lotion is composed of 5% of glycerin, 0.1% of 1% hyaluronic acid aqueous solution, and 94.9% water.
TABLE 1
Figure BDA0002686658180000071
Experimental results show that a stable system with good dispersion can be obtained by compounding the nano-silver and the conic gymnadenia rhizome extract. The nano silver, the conic gymnadenia rhizome extract and the chinaberry tree extract are compounded, a stable system with good dispersion can be obtained, and the appearance of the product is shown in figure 1.
Example 2 moisturizing test
1. The lotions of experimental groups 1 to 4 were prepared according to the raw materials and weight percentage ratios of table 2, wherein the conventional lotion consisted of 5% glycerol, 0.1% hyaluronic acid aqueous solution, and 94.9% water.
TABLE 2
Figure BDA0002686658180000072
The preparation method comprises the following steps:
1) Putting the raw materials into an emulsifying pot, mixing the raw materials together, and stirring the mixture into a uniform mixture at the temperature of between 40 and 80 ℃;
2) Adjusting the pH of the mixture to 5.0-8.0
3) And filtering the mixture in the emulsifying pot, and cooling the filtered mixture to room temperature to obtain a finished product.
2. Cleaning the arm, air-drying for half an hour, respectively taking five square areas of 2 multiplied by 2cm on the forearm of the arm, detecting the water content of the stratum corneum of the skin, respectively smearing five samples of the toning lotion of experimental groups 1-4 and the water of a blank control group in different areas, taking 0.1ml of each sample, detecting once every 2 minutes after smearing and complete absorption, then detecting once every half an hour for 4 times, wherein the detection data is the water content of the stratum corneum of the skin. The results are shown in Table 3. Blank is 100% deionized water.
TABLE 3
Numbering 0min 2min 30min 60min 90min
Experimental group 1 31.28% 50.22% 46.04% 44.22% 44.44%
Experimental group 2 32.81% 58.22% 57.76% 53.02% 50.32%
Experimental group 3 33.62% 56.32% 57.63% 53.52% 53.46%
Experimental group 4 36.52% 43.40% 42.00% 42.12% 41.14%
Experimental group 5 33.38% 56.06% 55.18% 52.46% 51.82%
Blank group 34.76% 42.68% 41.40% 41.08% 41.02%
According to the results in table 3, the experimental groups 2 and 3 can greatly improve the water content of the stratum corneum of the skin and have strong water replenishing and moisturizing capabilities compared with other samples. Proves that the skin epidermis moisturizing effect of the product can be obviously improved when the sample contains the arethusa extract (the gymnadenia conopsea extract). The moisture content of the stratum corneum of the experimental group 3 was maintained at a relatively high level for a period of time, and did not decrease continuously with time, as compared to the moisture content of the stratum corneum of the experimental group 2, so that the sample of the experimental group 3, which contained nano-silver, the gymnadenia conopsea extract, and the neem tree extract at the same time, had the best moisturizing effect.
Example 3 antimicrobial test
1. Lotions were prepared according to the raw materials and weight percentages in table 4.
TABLE 4
Figure BDA0002686658180000081
Figure BDA0002686658180000091
2. Test medium and strain
Culture medium:
TSB culture medium tryptone soya broth
YM Medium Yeast malt extract Medium
Letheen broth culture medium USP special culture medium for cosmetic preservation test
Lecithin Tween culture medium
Monglara red medium
Strain:
Figure BDA0002686658180000092
3. experimental method referring to the microorganism inspection method in chapter V of technical Specification for safety of cosmetics (2015), the concrete steps are shown in FIG. 2, the strains are divided into bacteria and fungi for experiment, and 10 inoculating bacteria and fungi are inoculated into culture medium on day 0 6 cfu/ml bacteria and fungi, and observing the growth state of the bacteria and fungi by taking 1ml of culture medium at 25 ℃ under the environment of 60% humidity on the 7 th day, 14 th day, 21 th day and 28 th day of culture.
The experimental results are shown in table 3, and the judgment criteria of the results are: the total number of colonies of the bacteria is reduced by 99.9% at the 7 th day, and no increase is generated at the 28 th day; the fungus is judged to be preserved if the fungus is reduced by 99.0% at the 14 th day and does not grow until 28 days, otherwise, the fungus is not preserved.
TABLE 5
Figure BDA0002686658180000093
Figure BDA0002686658180000101
According to the results in the table, the control groups 1, 2 and 3 respectively contain one or more of nano silver and chinaberry plant extracts, and the preservation challenge tests of the control groups all fail, and the control groups do not have the preservation effect. And meanwhile, the experiment group containing the nano silver, the chinaberry extract and the conic gymnadenia rhizome extract has successful anticorrosion challenge test and has anticorrosion effect. It is stated that in the composition, in order to achieve the desired bacteriostatic effect, the nano-silver, the chinaberry extract and the orchidaceae plant extract must be contained at the same time.
Example 4 safety test
1. Laboratory animal
Healthy male SPF-grade mice 6-8 weeks old, with a body weight of (25 + -2) g. Raising at 25 + -2 deg.C and humidity of 40 + -10%.
2. Establishment, grouping and administration of animal models
Mice were randomly grouped, 6 mice per group. The back side of the shaved and cleaned mouse was divided into two areas (2.5 cm. Times.2.5 cm), 0.5g of skin care lotion of each formulation group was applied to the left side, and a blank control was applied to the right side, which was covered with gauze and fixed with adhesive tape, and skin reactions at the applied site were observed after 1h, 24h, and 48 h.
After 14 consecutive days of application, the skin reaction at the site of application was observed and recorded. The skin was evaluated for irritation response and irritation intensity with reference to "evaluation procedure and method for cosmetic safety".
The result shows that although the skin care lotion containing the composite bacteriostatic agent has strong bacteriostatic and moisturizing capabilities, after the skin care lotion is continuously applied for 14 days, 2 mice in an experimental group have slight erythema phenomenon; 1 only a slight edema phenomenon appeared. The skin care lotion containing the composite bacteriostatic agent of the invention is shown to have slight inflammation in the using process. In order to solve the problem, the invention further optimizes the composite bacteriostatic agent.
The inventor respectively compounds more than 20 active ingredients from plants with the composite bacteriostatic agent, screens out 8 active ingredients which can be stably compounded with the composite bacteriostatic agent, and then tests the skin irritation experiment, and the result shows that the skin irritation defect can be eliminated by adding 0.1% of saponin and 0.01% of glycyrrhetinic acid into the composite bacteriostatic agent. By using the optimized formula, the skin of each mouse in 6 mice in the experimental group has no edema and erythema compared with the skin without the skin care lotion, and the skin care lotion after optimization is proved to have no irritation to the skin.
The finally optimized compound bacteriostatic agent comprises the following components in parts by weight:
0.02-0.20 weight part of nano silver;
0.10-10 parts by weight of chinaberry extract;
5-20 parts of gymnadenia conopsea extract;
0.05 to 0.20 weight portion of saponin;
0.01-0.02 weight part of glycyrrhetinic acid.
Example 5 moisturizing and antibacterial testing of skin emulsions
The skin care emulsion was prepared in the following manner, wherein the conventional skin care emulsion is a general product commercially available.
1. Preparing the raw materials
Taking 0.10g of nano-silver, 0.30g of chinaberry plant extract, 10.00g of gymnadenia conopsea extract, 0.1g of saponin and 0.01g of glycyrrhetinic acid, and adding traditional skin care lotion to 100g.
2. Mixing and stirring
The raw materials obtained in the first step are put into an emulsifying pot, mixed together and stirred into a uniform mixture at the temperature of 40 ℃.
3. Adjusting the pH of the mixture
The pH of the mixture obtained in step 2 was adjusted to 7.5.
4. Filtering, cooling to obtain the final product
Filtering the mixture in the emulsifying pot at 30-45 ℃, and cooling the filtered mixture to room temperature to obtain a finished product.
The prepared skin care emulsion was subjected to a moisturizing test according to the method of example 2, and the test results were: the skin care emulsion prepared by the invention can greatly improve the water content of the skin cuticle and has strong water replenishing and moisturizing capabilities.
The prepared skin care emulsion was subjected to an antibacterial test according to the method of example 3, and the test results were: the skin care emulsion prepared by the invention has antibacterial activity.
The prepared skin care emulsion was subjected to a safety test according to the method of example 4, and the test results were: the skin care emulsion prepared by the invention has good safety.
Example 4 moisturizing and antibacterial tests of hand lotions
The hand sanitizer was prepared as follows, wherein the conventional hand sanitizer is a common product on the market.
1. Preparing the raw materials
Taking 0.07g of nano-silver, 0.6g of chinaberry plant extract, 15g of gymnadenia conopsea extract, 0.15g of saponin and 0.02g of glycyrrhetinic acid, and adding the traditional hand sanitizer to 100g.
2. Mixing and stirring
The raw materials obtained in the first step are put into an emulsifying pot, mixed together and stirred into a uniform mixture at 40 ℃.
3. Adjusting the pH of the mixture
The pH of the mixture obtained in the second step was adjusted to 7.5.
4. Filtering, cooling to obtain the final product
Filtering the mixture in the emulsifying pot at 30-45 ℃, and cooling the filtered mixture to room temperature to obtain a finished product.
The prepared hand sanitizer is subjected to a moisturizing test according to the method in example 2, and the test result is as follows: the hand sanitizer prepared by the invention can greatly improve the water content of the skin cuticle and has strong water replenishing and moisturizing capabilities.
The prepared hand sanitizer is subjected to an antibacterial test according to the method of example 3, and the test result is as follows: the hand sanitizer prepared by the invention has antibacterial activity.
The prepared hand sanitizer is subjected to a safety test according to the method of example 4, and the test result is as follows: the hand sanitizer prepared by the invention has good safety.
Example 5 moisturizing and antibacterial tests of body wash
The hand sanitizer was prepared as follows, with a conventional body wash being a common product on the market.
1. Preparing the raw materials
Taking 0.05g of nano-silver, 1.0g of chinaberry plant extract and 12g of conic gymnadenia rhizome extract, and adding traditional shower gel to 100g.
2. Mixing and stirring
The raw materials obtained in the first step are put into an emulsifying pot, mixed together and stirred into a uniform mixture at the temperature of 40 ℃.
3. Adjusting the pH of the mixture
The pH of the mixture obtained in the second step was adjusted to 7.5.
4. Filtering, cooling to obtain the final product
Filtering the mixture in the emulsifying pot at 30-45 ℃, and cooling the filtered mixture to room temperature to obtain a finished product.
The prepared hand sanitizer is subjected to a moisturizing test according to the method of example 2, and the test result is as follows: the hand sanitizer prepared by the invention can greatly improve the water content of the skin cuticle and has strong water replenishing and moisturizing capabilities.
The prepared hand sanitizer is subjected to an antibacterial test according to the method of example 3, and the test result is as follows: the hand sanitizer prepared by the invention has antibacterial activity.
The prepared hand sanitizer is subjected to a safety test according to the method of example 4, and the test result is as follows: the hand sanitizer prepared by the invention has good safety.
All documents referred to herein are incorporated by reference into this application as if each were individually incorporated by reference. Furthermore, it should be understood that various changes and modifications of the present invention can be made by those skilled in the art after reading the above teachings of the present invention, and these equivalents also fall within the scope of the present invention as defined by the appended claims.

Claims (10)

1. The composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects is characterized by comprising the following components in parts by weight:
Figure FDA0003773081120000011
2. the composite bacteriostatic agent according to claim 1, which comprises the following components in parts by weight:
Figure FDA0003773081120000012
3. use of the composite bacteriostatic agent according to claim 1 in the preparation of cosmetics.
4. The use according to claim 3, wherein the cosmetic comprises skin lotion, hand wash and body wash.
5. Use according to claim 3, wherein the cosmetic product is a skin care emulsion.
6. A cosmetic comprising the complex bacteriostatic agent of claim 1.
7. The cosmetic of claim 6, wherein the cosmetic comprises skin lotion, hand cleanser and body wash.
8. The cosmetic of claim 6, wherein the cosmetic is a skin care lotion.
9. The preparation method of the composite bacteriostatic agent is characterized by comprising the following steps of:
(1) Mixing the raw materials of the composite bacteriostatic agent, and stirring the mixture at 40-80 ℃ to form a uniform mixture;
(2) Adjusting the pH value of the mixture to 5.0-8.0;
(3) Filtering the mixture, and cooling to room temperature to obtain the composite bacteriostatic agent;
the composite bacteriostatic agent comprises the following raw materials in parts by weight:
Figure FDA0003773081120000013
Figure FDA0003773081120000021
10. the method of claim 9, wherein the composite bacteriostatic agent raw material comprises the following components in parts by weight:
Figure FDA0003773081120000022
CN202010978341.1A 2020-09-17 2020-09-17 Composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects and preparation and application thereof Active CN112274462B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010978341.1A CN112274462B (en) 2020-09-17 2020-09-17 Composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects and preparation and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010978341.1A CN112274462B (en) 2020-09-17 2020-09-17 Composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects and preparation and application thereof

Publications (2)

Publication Number Publication Date
CN112274462A CN112274462A (en) 2021-01-29
CN112274462B true CN112274462B (en) 2022-10-18

Family

ID=74421092

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010978341.1A Active CN112274462B (en) 2020-09-17 2020-09-17 Composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects and preparation and application thereof

Country Status (1)

Country Link
CN (1) CN112274462B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113208944B (en) * 2021-05-17 2022-09-06 广东一方制药有限公司 Skin care composition and skin care product with moisturizing effect

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102600053B (en) * 2012-04-01 2013-04-24 西北师范大学 Chinese medicinal herb-inorganic antibacterial agent composite sterilization hand sanitizer and preparation thereof
CN102941354B (en) * 2012-12-05 2014-09-17 苏州大学 Preparation method of even and stable nano-silver water solution
CN104666100A (en) * 2015-02-02 2015-06-03 广东工业大学 Novel daily cosmetic antibacterial and antiseptic material and application thereof
CN106109326B (en) * 2016-07-30 2019-02-12 广东雅丽洁精细化工有限公司 A kind of anti-bacteria wet keeping facial mask and preparation method thereof containing plant extracts
CN106798716A (en) * 2017-02-22 2017-06-06 上海纳米技术及应用国家工程研究中心有限公司 Leave nanometer silver antimicrobial hand cleanser
CN107823222B (en) * 2017-10-25 2020-05-05 贵安新区瑞诚生物工程有限公司 Nano composite antibacterial agent and preparation method and application thereof
CN109157444A (en) * 2018-08-04 2019-01-08 中山市妙洁精细化工有限公司 A kind of mild hand cleanser of long-acting bacteriostatic and preparation method thereof
CN111184757A (en) * 2020-03-20 2020-05-22 蒋成聚 Plant folium artemisiae argyi extract and silver ion compound bactericide and preparation method thereof

Also Published As

Publication number Publication date
CN112274462A (en) 2021-01-29

Similar Documents

Publication Publication Date Title
CN107922956A (en) Glycerine derived from staphylococcus epidermis produces accelerating agent, the antimicrobial peptide derived from skin epidermis keratinocyte produces accelerating agent and their applications in skin sparing external preparation
CN110292552B (en) Compound plant extract with anti-allergy repairing effect and preparation method and application thereof
CN111214429B (en) Repair essence and preparation method thereof
CN106420596B (en) A kind of composition of the extract containing corn kernel and its application
CN110090190A (en) A kind of baby child plant is releived refrigerant liquid and preparation method thereof
CN108042380A (en) A kind of infant's activity stern protection cream and preparation method thereof
CN115317417A (en) Composition containing guaiacum extract for repairing acne sensitive muscle and skin care product thereof
CN112274462B (en) Composite bacteriostatic agent with bacteriostatic and epidermal moisturizing effects and preparation and application thereof
CN108309854A (en) A kind of lotus flower anti-aging cosmetics composition and its application
CN109453094B (en) Mosquito-repelling and itching-relieving composition and skin care product containing composition
US11154580B1 (en) Composition for preventing, ameliorating or treating acne symptoms using natural extracts as active ingredients
CN114432225A (en) Sunscreen skin care product and preparation method thereof
CN106377463A (en) Hydrating toner composition free from preservatives
CN112587458A (en) Preservative composition and preparation method and application thereof
KR101427462B1 (en) Composite Natural Antiseptics From Forsythia suspensa Vahl, Leonurus sibiricus L., Crataegi fructus and Akebia quinata Decaisne, Cosmetic Compositions Containing Them
KR102381645B1 (en) Cosmetic Composition Comprising Poria cocos Fermentation Extract
CN108451816A (en) A kind of inhibiting bacteria and diminishing inflammation acne-removing composition
CN114587767A (en) Cold compress cover, eye cold compress eye patch and preparation process thereof
Wickens et al. A search for novel biologically active compounds in the phyllodes of Acacia species.
CN115227592A (en) Bacteriostatic composition and application thereof
CN115136968A (en) Natural preservative containing camellia oleifera extract and preparation method thereof
CN112842976B (en) Yeast fermented birch juice and its application in anti-inflammatory cosmetic composition
KR101072731B1 (en) Fermentation composition using verniciflua the manufacturing method
JP3487619B2 (en) 5α-reductase inhibitor
CN112870140A (en) Anti-allergy itching-relieving composition, skin-care gel, and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant